论文信息 - Precision Psychiatry—Will Genomic Medicine Lead the Way? - 字舞流文

Precision Psychiatry—Will Genomic Medicine Lead the Way?

J. Smoller | M. Stein | M. Stein

[1] Paul B Ginsburg,et al. Encouraging New Uses for Old Drugs , 2017, JAMA.

[2] M. Paulus. Evidence-Based Pragmatic Psychiatry-A Call to Action. , 2017, JAMA psychiatry.

[3] G. Breen,et al. Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach , 2017, Scientific Reports.

[4] S. Kathiresan. Heart disease: Putative medicines that mimic mutations , 2017, Nature.

[5] S. Kathiresan,et al. Leveraging human genetics to guide drug target discovery. , 2017, Trends in cardiovascular medicine.

[6] Dermot F. Reilly,et al. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting , 2017, Circulation.

[7] Markus Perola,et al. Genomic prediction of coronary heart disease , 2016, bioRxiv.

[8] Olle Melander,et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.

[9] Gerome Breen,et al. Psychiatric Genomics: An Update and an Agenda , 2017, bioRxiv.